Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Oral almotriptan in the treatment of migraine: Safety and tolerability
David W. Dodick
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
53
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oral almotriptan in the treatment of migraine: Safety and tolerability'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
almotriptan
100%
Migraine Disorders
57%
Sumatriptan
49%
Safety
33%
Thorax
19%
Controlled Clinical Trials
15%
Incidence
10%
Tryptamines
10%
Migraine without Aura
9%
Migraine with Aura
9%
Therapeutics
9%
Clinical Trials
9%
Paresthesia
8%
Dizziness
7%
Nausea
6%
Vomiting
6%
Headache
6%
Fatigue
6%
Volunteers
6%
Pharmacokinetics
5%
Placebos
4%
Pressure
4%
Pharmaceutical Preparations
2%